newsfilter
← Latest News
GlobeNewswire·

AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Review and Approval Process in China

BEIJING, July 26, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx) kit, developed in partnership with CStone Pharmaceutical